A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)

Project: Research

Status	Active
Effective start/end date	20/02/20 → 19/02/25

Project Details